Skip to main content
SH

Sender Herschorn

Biography​

Sender Herschorn is a professor in the University of Toronto Division of Urology and an attending urologist at Sunnybrook Health Sciences Centre.1 He graduated from McGill University Medical School in 1972 and completed urology training at the University of Toronto in 1978.1 He completed clinical fellowships in urodynamics, incontinence, and reconstruction in 1979 at the Institute of Urology in London and Baylor College of Medicine in Houston.1 He is a former president of the Canadian Urological Association and a former general secretary of the International Continence Society.1

Contributions​

Herschorn's cited work covers urinary incontinence treatment, including onabotulinumtoxinA trials, urethral bulking agents for female stress incontinence, and male slings after prostatectomy. Other cited papers address augmentation cystoplasty, Hemi-Kock continent stomas, and vaginal fistula repair.23456

Cited on WARWIKI

17 publications with Sender Herschorn as a listed author are cited on WARWIKI, ordered by the number of pages that cite them. Papers whose author list is shortened to "et al." before this name are not included.

  1. Nitti VW, Dmochowski R, Herschorn S, et al. "OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo-controlled trial." J Urol. 2013;189(6):2186–2193. doi
    Cited on: Botulinum Toxin (Neuromodulation Adjunct) · Botulinum Toxin (OnabotulinumtoxinA & Variants) · Intradetrusor OnabotulinumtoxinA
  2. Cruz F, Herschorn S, Aliotta P, et al. "Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial." Eur Urol. 2011;60(4):742–750. doi
    Cited on: Botulinum Toxin (Neuromodulation Adjunct) · Botulinum Toxin (OnabotulinumtoxinA & Variants) · Intradetrusor OnabotulinumtoxinA
  3. Thomas HS, Stern N, Neu S, Herschorn S. Drug-coated balloon dilation for female urethral stricture. Urol Case Rep. 2025;59:102985. doi
    Cited on: Female DVIU and Urethral Dilation · Drug-Coated Balloon Therapy
  4. Welk BK, Herschorn S. The male sling for post-prostatectomy urinary incontinence: a review of contemporary sling designs and outcomes. BJU Int. 2012;109(3):328–344. doi
    Cited on: AdVance / AdVance XP — Retrourethral Transobturator Male Sling · ATOMS — Adjustable Transobturator Male System
  5. Ghoniem G, Corcos J, Comiter C, Westney OL, Herschorn S. Durability of Urethral Bulking Agent Injection for Female Stress Urinary Incontinence: 2-Year Multicenter Study Results. The Journal of Urology. 2010;183(4):1444-1449. doi
    Cited on: Macroplastique — Polydimethylsiloxane (PDMS) · Urethral Bulking Agents
  6. Herschorn S, Carrington E. "S-shaped coaxial dilators for male urethral strictures." Urology. 2007;69(6):1199–201. doi
    Cited on: Filiforms & Followers · S-Shaped Coaxial Dilators
  7. Neu S, Matta R, Herschorn S. "Transvaginal vesicovaginal fistula repair-high success with low morbidity despite radiation or prior repair." World J Urol. 2026;44(1):150. doi
    Cited on: Vesicovaginal Fistula
  8. Herschorn S, Locke J, Vigil H. Hemi-Kock continent stoma with augmentation cystoplasty: modifications and outcomes. Urology. 2022;160:217–222. doi
    Cited on: Hemi-Kock Continent Stoma
  9. Locke JA, Neu S, Herschorn S. Morbidity and predictors of delayed recognition of iatrogenic ureteric injuries. Can Urol Assoc J. 2022;15(1):E1–E6. PMID 34464249.
    Cited on: Ureteral Trauma
  10. Locke JA, Neu S, Herschorn S. "Diagnosis and Management of Kock Afferent Nipple Valve Obstruction." Urology. 2021;152:173–7. doi
    Cited on: Kock Pouch
  11. Neu S, Locke J, Goldenberg M, Herschorn S. "Urethrovaginal fistula repair with or without concurrent fascial sling placement: a retrospective review." Can Urol Assoc J. 2021;15(5):E276–E280. doi
    Cited on: Urethrovaginal Fistula Repair
  12. Comiter CV, Rhee EY, Tu LM, Herschorn S, Nitti VW. The Virtue sling — a new quadratic sling for postprostatectomy incontinence — results of a multinational clinical trial. Urology. 2014;84(2):433–438. doi
    Cited on: Virtue Quadratic Male Sling

Footnotes​

  1. Sender Herschorn Division of Urology, University of Toronto. Accessed October 2026. ↩ ↩2 ↩3 ↩4

  2. Nitti VW, Dmochowski R, Herschorn S, et al. "OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo-controlled trial." J Urol. 2013;189(6):2186–2193. doi:10.1016/j.juro.2012.12.022 ↩

  3. Cruz F, Herschorn S, Aliotta P, et al. "Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial." Eur Urol. 2011;60(4):742–750. doi:10.1016/j.eururo.2011.07.002 ↩

  4. Ghoniem G, Corcos J, Comiter C, Westney OL, Herschorn S. Durability of Urethral Bulking Agent Injection for Female Stress Urinary Incontinence: 2-Year Multicenter Study Results. The Journal of Urology. 2010;183(4):1444-1449. doi:10.1016/j.juro.2009.12.038 ↩

  5. Welk BK, Herschorn S. The male sling for post-prostatectomy urinary incontinence: a review of contemporary sling designs and outcomes. BJU Int. 2012;109(3):328–344. doi:10.1111/j.1464-410x.2010.10502.x ↩

  6. Herschorn S, Glazer AA. Early Experience With Small Volume Periurethral Polytetrafluoroethylene for Female Stress Urinary Incontinence. The Journal of Urology. 2000;163(6):1838-1842. PubMed. ↩